JACI: In Practice Response to COVID-19 Pandemic

Publication date: Available online 6 April 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Dawn M. Angel, Robert S. Zeiger, Scott H. Sicherer, David A. Khan, Michael Schatz
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research

Related Links:

Discussions with the FDA are ongoing to define the required data set for filing Janssen’s Ebola vaccine regimen under the FDA’s Animal Rule licensure pathway. About Janssen’s Ebola Vaccine Regimen The Janssen investigational preventive Ebola vaccine regimen (Ad26.ZEBOV, MVA-BN-Filo) utilizes a viral vector strategy in which viruses – in this case adenovirus serotype 26 (Ad26) and Modified Vaccinia Virus Ankara (MVA) – are genetically modified so that they cannot replicate in human cells. In addition, these vectors are modified to safely carry the genetic code of an Ebola virus protein in order...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Publication date: Available online 27 May 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Vitor Oliveira Carvalho, Caroline Oliveira Gois
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
WebMD Chief Medical Officer John Whyte talks with Dr Luciana Borio about the failures of the US response to the coronavirus pandemic and how much longer physical distancing will be necessary.WebMD
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Public Health & Prevention Expert Interview Source Type: news
AbstractCoronavirus disease 2019 (COVID-19) is a global pandemic infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and abnormal, overactivated innate immunity and “cytokine storms” have been proposed as potential pathological mechanisms for rapid COVID-19 progression. Theoretically, asthmatic patients should have increased susceptibility and severity for SARS-CoV-2 infection due to a deficient antiviral immune response and the tendency for exacerbation el icited by common respiratory viruses. However, existing studies have not shown an expected prevalence of asthmatic in...
Source: Clinical Reviews in Allergy and Immunology - Category: Allergy & Immunology Source Type: research
SARS-CoV-2 infection and development of COVID-19 disease presents a major healthcare challenge of global dimensions. Laboratory diagnostics of infected patients, and the assessment of immunity against the SARS-CoV-2 virus presents a major cornerstone in handling the pandemic. Currently there is an increase in demand of antibody testing and a large number of tests are already marketed or in the late stage of development. However, the interpretation of test results depends on many variables and factors, including sensitivity, specificity, potential cross-reactivity and cross-protectivity; the diagnostic value of antibodies o...
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research
Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci told CNN's Jim Sciutto that he wears a mask because it's effective and to set an example for others during the coronavirus pandemic.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
The U.S. House of Representatives passed a new coronavirus relief package, The Heroes Act, on May 15, 2020. If passed by the Senate and signed by the President, this will be the fifth measure adopted by Congress to respond to the COVID-19 pandemic. The $3 trillion stimulus bill includes $1 trillion in assistance for state, local, territorial, and tribal governments; $75 billion for coronavirus testing, contact tracing, and isolation measures; emergency supplemental appropriations to federal agencies; another round of direct payments; and $200 billion for a “Heroes’ fund” to provide hazard pay for essenti...
Source: Public Policy Reports - Category: Biology Authors: Source Type: news
This study showed that a five-day regimen is as effective as 10 days–that’s important, doctors say, since it could mean shorter stays in the hospital, which could alleviate some of the burden on the health care system. “Of course we will have to wait for the final review of all the data, but it would be very nice to have an anti-viral that’s efficacious in this terrible illness,” says Dr. Aruna Subramanian, a clinical professor of medicine at Stanford and an investigator on the study. “At least we know that we can help patients with this, and that’s really the bottom line.” T...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 feature Magazine Source Type: news
Like COVID-19's symptoms, the pandemic's effect on physician income has been worse for some specialties than for others. Here's a rundown of how various doctors are dealing financially.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Family Medicine/Primary Care News Source Type: news
While most people are familiar with the hallmark symptoms of COVID-19 by now—cough, fever, muscle aches, headaches and difficulty breathing—a new crop of medical conditions are emerging from the more than 4 million confirmed cases of the disease around the world. These include skin rashes, diarrhea, kidney abnormalities and potentially life-threatening blood clots. It’s not unusual for viruses to directly infect and affect different tissues and organs in the body, but it is a bit unusual for a primarily respiratory virus like SARS-CoV-2, which is responsible for COVID-19, to have such a wide-ranging reach...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
More News: Allergy | Allergy & Immunology | COVID-19 | Pandemics